伴随着2025年年报披露的拉开序幕，热门赛道的核心公司业绩是否能持续支撑高估值，成为许多基本面投资者关注的焦点。 披露时间来看，业绩预告早于业绩快报，早于定期报告。以年报为例，①年度业绩预告于1月31日前披露，沪市、深市主板、创业板公司若出现净利润亏 损、扭亏为盈、净利润同比变动±50%以上、净资产为负（深市主板、创业板）必须强制披露；②业绩快报于2月底前披露，其中深市中小板、创业板公 司，若年报预约披露时间为3-4月，需强制发布年度业绩快报。沪市主板、深市主板公司可自愿披露，非强制；③年报正式披露介于1月-4月，其中3 月-4 月为集中披露期。 | | 25 年 1 月 | 25年２月 | 25年3月 | 25年4月 | | --- | --- | --- | --- | --- | | 2024 年报 业绩预告数量 | 2759 | ব | 32 | 75 | | 2024 年报 业绩快报数量 | 74 | 886 | 114 | 80 | | 2024 年报 定期报告数量 | | ટર | 964 | 4408 | 而从实务效果看，以Go-Goal每季度业绩超预期公司做成的组合看，2012年至今，业绩超 ...

Core Viewpoint - The A-share market is experiencing a collective pullback, with the ChiNext index leading the decline, indicating increased short-term adjustment pressure and a shift in market sentiment towards defensive sectors [5][7]. Market Performance - The Shanghai Composite Index is at 4138.76, with 1619 stocks rising and 3726 stocks falling, reflecting a poor profit-making effect in the market [9][5]. - The trading volume in both markets has exceeded 3 trillion yuan for three consecutive days, marking a historical high, supported by both incremental and existing capital adjustments [5]. Capital Flow - There is a net outflow of 805.56 billion yuan from institutional funds, while retail investors are showing a net inflow [6]. - Institutions are exhibiting a "risk-averse and divergent strategy," reallocating funds from high-growth sectors like commercial aerospace and AI applications to undervalued defensive stocks such as banks and pharmaceuticals [7]. Investor Sentiment - Retail investor sentiment shows that 75.85% are cautious, with 36.99% increasing their positions and 19.78% reducing them, indicating a shift towards more defensive strategies [8][11].

康龙化成表示，在主营业务持续向好的情形下，主要由于非经常性损益的下降，公司归属净利润相比上 年同期下降6%-10%。上年同期主要由于处置PROTEOLOGIX, INC.股权影响，归属于上市公司股东的非 经常性损益为68543.7万元。 北京商报讯（记者 丁宁）1月13日晚间，康龙化成（300759）发布2025年度业绩预告显示，公司预计 2025年实现归属净利润16.14亿元至16.86亿元，比上年同期下降6%–10%。 ...

Market Overview - The A-share market experienced a phase adjustment on January 13, ending a 17-day winning streak, with the Shanghai Composite Index closing at 4138.76 points, down 0.64% [1][3] - Despite the pullback, trading volume remained robust, with total turnover in the Shanghai, Shenzhen, and Beijing markets exceeding 3.69 trillion yuan, setting a new historical record [1][3] Sector Performance - Leading sectors during this period included artificial intelligence and commercial aerospace, with significant profit potential yet to be fully realized [1] - The number of stocks that rose exceeded 1600, with over 70 stocks hitting the daily limit up. The precious metals, medical services, mining, and biopharmaceutical sectors showed the highest gains, while aerospace, communication equipment, computer devices, shipbuilding, semiconductors, and electronic chemicals faced the largest declines [3][4] Individual Stock Highlights - Several stocks in the commercial aerospace sector experienced significant declines, with multiple stocks hitting the daily limit down. Notably, companies in this sector have issued risk warning announcements recently [4][5] - Aerospace Development, focused on defense information technology and low-orbit satellite operations, reported that its revenue contribution from satellite operations is minimal, accounting for less than 1% of total revenue in the first three quarters of 2025, indicating limited impact on overall performance [5] Analyst Insights - Analysts from various brokerages noted that the market's concern remains around the adjustment risks following a sustained increase in trading volume. Historical trends suggest that significant volume increases often lead to market volatility, especially after a long winning streak [7] - Overall, the market is viewed as relatively healthy, with concentrated profit effects yet to fully diffuse. However, a potential shift in popular sectors may occur, leading to market fluctuations [7][8] - The technology growth sector is experiencing healthy rotation, while cyclical stocks like non-ferrous metals and chemicals are trending upward. Analysts recommend a cautious approach, focusing on structural investments while managing profit-taking strategies [8]

金域医学表示，主要原因是由于部分应收账款回款周期延长，导致产生较大的信用减值损失。 北京商报讯(记者丁宁)1月13日晚间，金域医学（603882）发布公告称，经公司财务部门初步测算，预 计2025年年度归属净利润为负值，公司2025年年度经营业绩将出现亏损。 ...

智通财经APP讯，康龙化成(300759.SZ)发布2025年年度业绩预告，预计2025年度归属于上市公司股东的 净利润16.14亿元至16.86亿元，同比下降6%–10%。 经公司初步测算，2025年度归属于上市公司股东的非经常性损益约为人民币11,000 万元至人民币13,000 万元，主要包括计入当期损益的政府补助、其他非流动金融资产公允价值变动收益及投资的中低风险银 行理财产品相关损益等。 ...

每经AI快讯，迪安诊断发布公告称，2026年1月11日，迪安诊断接受国信证券组织的投资者调研，公司 副总裁、首席信息官吴维严等人参与接待，并回答了投资者提出的问题。 每经头条（nbdtoutiao）——"春节也要加班，抢在4月1日前交货"！有光伏企业在抢出口，也有企业很 纠结：白银等原材料成本激增，决策困难 （记者 王晓波） ...

21智讯1月13日电，康龙化成发布年度业绩预告，预计2025年全年归属于上市公司股东的净利润为 161401.57万元—168574.98万元，同比预减6.00%—10.00%；预计2025年全年归属于上市公司股东的扣 除非经常性损益的净利润为150676.29万元—156215.86万元，同比预增36.00%—41.00%，变动原因为： 公司坚定地推行"全流程、一体化、国际化、多疗法"的核心战略，以客户需求为导向，深化全球化布 局，强化技术平台建设。2025年，公司预计营业收入同比增长13%—16%、归属于上市公司股东的扣除 非经常性损益后的净利润同比增长36%—41%、经调整的非《国际财务报告准则》下归属于上市公司股 东的净利润同比增长10%—15%。按业绩预告中位值测算，2025年第四季度，公司营业收入同比增长 14.79%、归属于上市公司股东的扣除非经常性损益后的净利润同比增长54.09%、经调整的非《国际财 务报告准则》下归属于上市公司股东的净利润同比增长16.36%。如上所述，报告期内归属于上市公司 股东的非经常性损益为人民币11,000万元至人民币13,000万元；上年同期主要由于处置 PROT ...

康龙化成公告称，康龙化成预计2025年归属于上市公司股东的净利润为16.14亿元-16.86亿元，比上年同 期下降6%-10%。报告期内，公司营业收入同比增长13%-16%，扣除非经常性损益后的净利润同比增长 36%-41%。 （文章来源：第一财经） ...

康龙化成公告，预计2025年度净利润为16.14亿元–16.86亿元，同比下降6%–10%。预计营业收入为 138.72亿元–142.4亿元，同比增长13%–16%。预计归属于上市公司股东的扣除非经常性损益后的净利润 为15.07亿元–15.62亿元，同比增长36%–41%。 ...